A-967079 is primarily used in research settings to study the role of TRPA1 (Transient Receptor Potential Ankyrin 1) channels in various physiological and pathological processes. It acts as a potent and selective antagonist of TRPA1, making it valuable for investigating pain mechanisms, inflammatory responses, and sensory signaling pathways. Researchers utilize this compound to explore its potential in managing chronic pain conditions, such as neuropathic pain, and to understand its effects on conditions like asthma, irritable bowel syndrome, and other TRPA1-related disorders. Its application extends to preclinical studies aimed at developing novel therapeutic strategies targeting TRPA1 channels.